Thromboembolism during pregnancy: Risks, challenges, and recommendations

Postgraduate Medicine

Volumn 108, Issue 4, 2000, Pages 71-84

  Sellman, Jonathan S ^a,d   Holman, Russell L ^b,c  

^a University of Minnesota Residency Program   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Health Partners Medical Group   (United States)

^d REGIONS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; DALTEPARIN; DANAPAROID; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; HEPARIN DERIVATIVE; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; PLASMINOGEN ACTIVATOR; STREPTOKINASE; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG HALF LIFE; DRUG INDICATION; ENDOTHELIUM INJURY; FEMALE; GENETIC DISORDER; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; PREGNANCY; PROGNOSIS; THROMBOEMBOLISM;

EID: 0034665427     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.09.15.1238     Document Type: Conference Paper

References (29)

1. Incidence and diagnosis of deep venous thrombosis associated with pregnancy
2. Pregnancy-related mortality surveillance - United States, 1987-1990
3. Thrombosis in pregnancy: Maternal and fetal issues
4. Venous thromboembolism during pregnancy
5. Venous thrombosis during pregnancy: Leg and trimester of presentation
6. Prevention of venous thrombosis pulmonary embolism. NIH Consensus Development
7. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy
8. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis
9. Deep venous thrombosis during pregnancy: A prospective study
10. Distinguishable types of dyspnea in patients with shortness of breath
11. Alveolararterial gradient in acute pulmonary embolism in pregnancy
12. D-dimer concentrations during normal pregnancy, as measured by ELISA
13. Fetal dosimetry from pulmonary imaging in pregnancy: Revised estimates
14. Pulmonary imaging in pregnancy: Maternal risk and fetal dosimetry
15. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease
16. Pulmonary embolus in pregnant patients: Survey of ventilation-perfusion imaging policies and practices
17. The AAPM/RSNA physics tutorial for residents: Typical patient radiation doses in diagnostic radiology
18. Maternal and fetal sequelae of anticoagulation during pregnancy
19. Risks to the fetus of anticoagulant therapy during pregnancy
20. Heparin therapy during pregnancy. Risks to the fetus and mother
21. Thromboembolism and pregnancy
22. Heparin-induced thrombocytopenia
23. Heparin levels to guide thromboembolism prophylaxis during pregnancy
24. Use of antithrombotic agents during pregnancy
25. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep venous thrombosis
26. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydro-folate reductase C677T mutations
27. The challenge of thrombophilia in maternal-fetal medicine
28. Risk factors for pregnancy associated venous thromboembolism
29. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies